- Home
- CLLS vs EVC Comparison
CLLS vs EVC Comparison
Compare CLLS & EVC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CLLS
- EVC
- Stock Information
- Founded
- CLLS 1999
- EVC 1996
- Country
- CLLS France
- EVC United States
- Employees
- CLLS N/A
- EVC N/A
- Industry
- CLLS Biotechnology: Pharmaceutical Preparations
- EVC Broadcasting
- Sector
- CLLS Health Care
- EVC Industrials
- Exchange
- CLLS Nasdaq
- EVC Nasdaq
- Market Cap
- CLLS 144.4M
- EVC 171.0M
- IPO Year
- CLLS 2007
- EVC 2000
- Fundamental
- Price
- CLLS $1.49
- EVC $1.98
- Analyst Decision
- CLLS Buy
- EVC
- Analyst Count
- CLLS 3
- EVC 0
- Target Price
- CLLS $6.67
- EVC N/A
- AVG Volume (30 Days)
- CLLS 46.6K
- EVC 182.2K
- Earning Date
- CLLS 05-12-2025
- EVC 05-08-2025
- Dividend Yield
- CLLS N/A
- EVC 10.10%
- EPS Growth
- CLLS N/A
- EVC N/A
- EPS
- CLLS N/A
- EVC N/A
- Revenue
- CLLS $54,747,000.00
- EVC $378,623,000.00
- Revenue This Year
- CLLS $48.52
- EVC $64.06
- Revenue Next Year
- CLLS $5.17
- EVC N/A
- P/E Ratio
- CLLS N/A
- EVC N/A
- Revenue Growth
- CLLS 351.26
- EVC 23.10
- 52 Week Low
- CLLS $1.10
- EVC $1.58
- 52 Week High
- CLLS $2.78
- EVC $2.73
- Technical
- Relative Strength Index (RSI)
- CLLS 51.15
- EVC 52.49
- Support Level
- CLLS $1.46
- EVC $1.85
- Resistance Level
- CLLS $1.60
- EVC $2.11
- Average True Range (ATR)
- CLLS 0.08
- EVC 0.07
- MACD
- CLLS -0.01
- EVC 0.01
- Stochastic Oscillator
- CLLS 52.17
- EVC 56.40
About CLLS Cellectis S.A.
Cellectis SA is a clinical stage biotechnological company, employing the core proprietary technologies to develop products based on gene-editing, with a portfolio of allogeneic Chimeric Antigen Receptor T-cells, or UCART, product candidates in the field of immuno-oncology and gene-edited hematopoietic stem and progenitor cells, or HSPC product candidates in other therapeutic indications.
About EVC Entravision Communications Corporation
Entravision Communications Corp owns and operates Spanish language television and radio stations in the United States. The Company also owns and operates a smaller group of television stations that broadcast English language programming and has operations that provide programmatic advertising technology and services. The Company has organized its operations into two reportable segments. Its media segment includes its television, radio, and digital marketing operations. Its advertising and technology services segment provides programmatic advertising and technology services. The company generates the majority of its revenue from the Media segment. Geographically, the company generates the majority of its revenue from the United States.